LOADING
Tag: Simulations Plus
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
May 5, 2022
Simulations Plus, Inc., a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced that the U.S. Food and Drug Administration (FDA) has renewed its...
chat_bubble0 Comment
visibility330 Views
Official logo of ESG News (C) 2025